# OnCo record beijing-xunsheng-biomedical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/beijing-xunsheng-biomedical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "beijing-xunsheng-biomedical" ;
  schema:name "Beijing Xunsheng Biomedical Research"@en ;
  schema:alternateName "Aeonvital"@en, "Xunsheng Biotech"@en ;
  schema:description "Beijing Xunsheng Biomedical Research grows a patient's own tumour-fighting immune cells, taken from the tumour itself, and gives them back in large numbers. Its first cell therapy, ReT01, is aimed at cervical cancer and is in an early trial in advanced solid tumours; it is also developing DNA vaccines against HPV."@en ;
  schema:url <https://onco.cc/companies/beijing-xunsheng-biomedical/>, <http://www.aeonvital.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <http://www.aeonvital.com/>, <https://clinicaltrials.gov/study/NCT06257680>, <http://www.aeonvital.com/page141> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/til-therapy/> .